Indications
Maviret is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults and children aged 3 years and older. Maviret coated granules is indicated for the treatment of chronic hepatitis C virus (HCV) infection in children 3 years and older.
Composition
- Active substance
- glecaprevir, pibrentasvir
- International name (INN)
- glecaprevir;pibrentasvir
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Maviret
- Active substance
- glecaprevir, pibrentasvir
- ATC code
- J05AP57
- Therapeutic area
- Hepatitis C, Chronic